Evaluation of Apolipoprotein B / Apolipoprotein A Ratio as an Alternate of Lipid Profile for Cardiovascular Risk Assessment in a Tertiary Care Hospital

Objective: To compare the predictive utility of serum Apo B/Apo A ratio with serum lipid profile in evaluation of cardiovascular disease (CVD) risk assessment. Study Design: Cross sectional study. Place and Duration of Study: Research was done at Department of Chemical Pathology & Endocrinolog...

Descrizione completa

Dettagli Bibliografici
Autore principale:	Aqsa Mushtaq, Muhammad Younas, Zujaja Hina Haroon, Muhammad Usman Munir, Sayed Tanveer Abbas Gilani, Muhammad Anwar
Natura:	Articolo
Lingua:	English
Pubblicazione:	Riphah International University, Islamabad 2024-03-01
Serie:	Journal of Islamic International Medical College
Soggetti:	apo a apo b apo b/apo a ratio cardiovascular disease lipid profile.
Accesso online:	https://journals.riphah.edu.pk/index.php/jiimc/article/view/1860

Documenti analoghi

Human crypt intestinal epithelial cells are capable of lipid production, apolipoprotein synthesis, and lipoprotein assembly
di: Emile Levy, et al.
Pubblicazione: (2000-01-01)

The association of apolipoprotein in the risk of ST-elevation myocardial infarction in patients with documented coronary artery disease
di: Astuti Giantini, et al.
Pubblicazione: (2023-09-01)

Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins
di: Kathleen S. Montine, et al.
Pubblicazione: (1998-12-01)

Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma
di: Johan Björkegren, et al.
Pubblicazione: (1998-07-01)

ASSOCIATION OF CAROTID INTIMA-MEDIA THICKNESS WITH LEPTIN AND APOLIPOPROTEIN B/APOLIPOPROTEIN A-I RATIO REVEALS IMMINENT PREDICTORS OF SUBCLINICAL ATHEROSCLEROSIS IN PSORIASIS PATIENTS
di: Kumari Asha, et al.
Pubblicazione: (2014-01-01)

Apolipoprotein B/Apolipoprotein A1 ratio is an independent prognostic factor in pancreatic cancer
di: Chenxi Li, et al.
Pubblicazione: (2025-01-01)

Circulating growth differentiation factor 15 levels and apolipoprotein B to apolipoprotein A1 ratio in coronary artery disease patients with type 2 diabetes mellitus
di: Yufeng Mei, et al.
Pubblicazione: (2022-07-01)

Serum apolipoprotein B to apolipoprotein A‐I ratio predicts mortality in patients with heart failure
di: Shiyang Li, et al.
Pubblicazione: (2024-02-01)

Association of Glycated Haemoglobin and Serum Apolipoproteins with Diabetic Retinopathy: An Indian Overview
di: Bhasker Mukherjee, et al.
Pubblicazione: (2017-09-01)

Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content
di: Christina Khoo, et al.
Pubblicazione: (1999-02-01)

Serum apolipoprotein B/apolipoprotein A1 ratio in relation to intervertebral disk herniation: a cross-sectional frequency-matched case–control study
di: Fei Chen, et al.
Pubblicazione: (2021-07-01)

Single Nucleotide Polymorphisms in Apolipoprotein B, Apolipoprotein E, and Methylenetetrahydrofolate Reductase Are Associated With Serum Lipid Levels in Northern Chilean Subjects. A Pilot Study
di: Anita S. Gálvez, et al.
Pubblicazione: (2021-09-01)

THE EFFECT OF SUPPLEMENTARY CALCIUM ON SERUM LIPIDS, LIPOPROTEINS AND APOLIPOPROTEINS IN HEALTHY ADULT WOMEN AGED 18-30 YEARS
di: MH ENTEZARI, et al.
Pubblicazione: (2003-12-01)

Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro
di: Denise K. Bonen, et al.
Pubblicazione: (1998-08-01)

Enhanced atherosclerosis in apolipoprotein E knockout rabbits: role of apoB48-rich remnant lipoproteins
di: Manabu Niimi, et al.
Pubblicazione: (2024-07-01)

Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins
di: Wanda Vélez-Carrasco, et al.
Pubblicazione: (1999-09-01)

Serum apolipoprotein C3 levels are negatively associated with hepatitis B virus DNA in HBeAg-negative chronic hepatitis B patients
di: Yu Cui, et al.
Pubblicazione: (2019-06-01)

Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis
di: M. T. La Chica Lhoëst, et al.
Pubblicazione: (2024-06-01)

Rat McA-RH7777 cells efficiently assemble rat apolipoprotein B-48 or larger fragments into VLDL but not human apolipoprotein B of any size
di: Qunong Xiao, et al.
Pubblicazione: (2000-01-01)

Gene-Gene Interactions among Pparα/δ/γ Polymorphisms for Apolipoprotein (Apo) A-I/Apob Ratio in Chinese Han Population.
di: Bo Hai, et al.
Pubblicazione: (2014-06-01)

Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity
di: G.F. Watts, et al.
Pubblicazione: (2000-03-01)

Studies on the apoproteins of rat lymph chylomicrons: characterization and metabolism of a new chylomicron-associated apoprotein
di: N H Fidge, et al.
Pubblicazione: (1981-01-01)

Effects of toxic apolipoprotein E fragments on Tau phosphorylation and cognitive impairment in neonatal mice under sevoflurane anesthesia
di: Yang Yu, et al.
Pubblicazione: (2022-08-01)

ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice
di: Emanuel Voyiaziakis, et al.
Pubblicazione: (1998-02-01)

ApoB100 and Atherosclerosis: What’s New in the 21st Century?
di: Dimitris Kounatidis, et al.
Pubblicazione: (2024-02-01)

Levels of Angiotensin-Converting Enzyme and Apolipoproteins Are Associated with Alzheimer’s Disease and Cardiovascular Diseases
di: Chun Xu, et al.
Pubblicazione: (2021-12-01)

Comparison among the Atherogenic Index of Plasma, Ratios of Lipoproteins, Apolipoproteins and Cholesterol Retention Factor (CRF) inPatients with Metabolic Syndrome
di: Sikandar Hayat Khan, et al.
Pubblicazione: (2023-06-01)

An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis
di: Rosanne M. Crooke, et al.
Pubblicazione: (2005-05-01)

Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein
di: Francisco Blanco-Vaca, et al.
Pubblicazione: (2001-11-01)

Chylomicron apoprotein localization within rat intestinal epithelium: studies of normal and impaired lipid absorption1
di: R M Glickman, et al.
Pubblicazione: (1978-02-01)

The N-linked oligosaccharides at the amino terminus of human apoB are important for the assembly and secretion of VLDL
di: Jelena Vukmirica, et al.
Pubblicazione: (2002-09-01)

Apolipoprotein B - An ideal biomarker for atherosclerosis?
di: Kavita Singh, et al.
Pubblicazione: (2024-03-01)

Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma
di: Xin Cai, et al.
Pubblicazione: (2024-05-01)

Apolipoprotein (a) as Predictive Factor in Fibromyalgia Syndrome.
di: Lubna M. H. Farid, et al.
Pubblicazione: (2010-07-01)

A proteolytic method for distinguishing between lipid-free and lipid-bound apolipoprotein A-I
di: Wael Safi, et al.
Pubblicazione: (2001-05-01)

Effects of Sex on the Relationship Between Apolipoprotein E Gene and Serum Lipid Profiles in Alzheimer’s Disease
di: Jiajia Fu, et al.
Pubblicazione: (2022-05-01)

Apo B/Apo A-I Ratio is Statistically A Better Predictor of Cardiovascular Disease (CVD) than Conventional Lipid Profile: A Study from Kathmandu Valley, Nepal
di: Hem Kumar Tamang, et al.
Pubblicazione: (2014-02-01)

Association of cerebrospinal fluid NPY with peripheral ApoA: a moderation effect of BMI
di: Danyang Zhao, et al.
Pubblicazione: (2024-07-01)

Importance of lipid ratios for predicting intracranial atherosclerotic stenosis
di: Wen-Song Yang, et al.
Pubblicazione: (2020-07-01)

Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins
di: Eric E. Niederkofler, et al.
Pubblicazione: (2003-03-01)